Assessment of BCR-ABL1 Transcript Levels at 3 Months Is the Only Requirement for Predicting Outcome for Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors
MARIN, David, IBRAHIM, Amr R, PAVLU, Jiri, PALIOMPEIS, Christos, REID, Alistair, REZVANI, Katayoun, GOLDMAN, John M, FORONI, Letizia, LUCAS, Claire, GERRARD, Gareth, LIHUI WANG, SZYDLO, Richard M, CLARK, Richard E, APPERLEY, Jane F, MILOJKOVIC, Dragana, BUA, Marco
Published in Journal of clinical oncology (20.01.2012)
Published in Journal of clinical oncology (20.01.2012)
Get full text
Journal Article
Imatinib for Newly Diagnosed Patients With Chronic Myeloid Leukemia: Incidence of Sustained Responses in an Intention-to-Treat Analysis
DE LAVALLADE, Hugues, APPERLEY, Jane F, MARIN, David, KHORASHAD, Jamshid S, MILOJKOVIC, Dragana, REID, Alistair G, BUA, Marco, SZYDLO, Richard, OLAVARRIA, Eduardo, KAEDA, Jaspal, GOLDMAN, John M
Published in Journal of clinical oncology (10.07.2008)
Published in Journal of clinical oncology (10.07.2008)
Get full text
Journal Article
Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)
Hughes, Timothy P., Hochhaus, Andreas, Branford, Susan, Müller, Martin C., Kaeda, Jaspal S., Foroni, Letizia, Druker, Brian J., Guilhot, François, Larson, Richard A., O'Brien, Stephen G., Rudoltz, Marc S., Mone, Manisha, Wehrle, Elisabeth, Modur, Vijay, Goldman, John M., Radich, Jerald P.
Published in Blood (11.11.2010)
Published in Blood (11.11.2010)
Get full text
Journal Article
Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials
Branford, Susan, Fletcher, Linda, Cross, Nicholas C.P., Müller, Martin C., Hochhaus, Andreas, Kim, Dong-Wook, Radich, Jerald P., Saglio, Giuseppe, Pane, Fabrizio, Kamel-Reid, Suzanne, Wang, Y. Lynn, Press, Richard D., Lynch, Kevin, Rudzki, Zbigniew, Goldman, John M., Hughes, Timothy
Published in Blood (15.10.2008)
Published in Blood (15.10.2008)
Get full text
Journal Article
Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias
Walker, Christopher J., Oaks, Joshua J., Santhanam, Ramasamy, Neviani, Paolo, Harb, Jason G., Ferenchak, Gregory, Ellis, Justin J., Landesman, Yosef, Eisfeld, Ann-Kathrin, Gabrail, Nash Y., Smith, Carrie L., Caligiuri, Michael A., Hokland, Peter, Roy, Denis Claude, Reid, Alistair, Milojkovic, Dragana, Goldman, John M., Apperley, Jane, Garzon, Ramiro, Marcucci, Guido, Shacham, Sharon, Kauffman, Michael G., Perrotti, Danilo
Published in Blood (24.10.2013)
Published in Blood (24.10.2013)
Get full text
Journal Article
Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies
Oaks, Joshua J., Santhanam, Ramasamy, Walker, Christopher J., Roof, Steve, Harb, Jason G., Ferenchak, Greg, Eisfeld, Ann-Kathrin, Van Brocklyn, James R., Briesewitz, Roger, Saddoughi, Sahar A., Nagata, Kyosuke, Bittman, Robert, Caligiuri, Michael A., Abdel-Wahab, Omar, Levine, Ross, Arlinghaus, Ralph B., Quintas-Cardama, Alfonso, Goldman, John M., Apperley, Jane, Reid, Alistair, Milojkovic, Dragana, Ziolo, Mark T., Marcucci, Guido, Ogretmen, Besim, Neviani, Paolo, Perrotti, Danilo
Published in Blood (12.09.2013)
Published in Blood (12.09.2013)
Get full text
Journal Article
Finding of Kinase Domain Mutations in Patients With Chronic Phase Chronic Myeloid Leukemia Responding to Imatinib May Identify Those at High Risk of Disease Progression
KHORASHAD, Jamshid S, DE LAVALLADE, Hugues, MARIN, David, APPERLEY, Jane F, MILOJKOVIC, Dragana, REID, Alistair G, BUA, Marco, SZYDLO, Richard, OLAVARRIA, Eduardo, KAEDA, Jaspal, GOLDMAN, John M
Published in Journal of clinical oncology (10.10.2008)
Published in Journal of clinical oncology (10.10.2008)
Get full text
Journal Article
Relapse and Late Mortality in 5-Year Survivors of Myeloablative Allogeneic Hematopoietic Cell Transplantation for Chronic Myeloid Leukemia in First Chronic Phase
Goldman, John M, Majhail, Navneet S, Klein, John P, Wang, Zhiwei, Sobocinski, Kathleen A, Arora, Mukta, Horowitz, Mary M, Rizzo, J Douglas
Published in Journal of clinical oncology (10.04.2010)
Published in Journal of clinical oncology (10.04.2010)
Get full text
Journal Article
MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models
Mahon, François-Xavier, Belloc, Francis, Lagarde, Valérie, Chollet, Claudine, Moreau-Gaudry, François, Reiffers, Josy, Goldman, John M., Melo, Junia V.
Published in Blood (15.03.2003)
Published in Blood (15.03.2003)
Get full text
Journal Article
Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia
MILOJKOVIC, Dragana, NICHOLSON, Emma, KHORASHAD, Jamshid S, DE LAVALLADE, Hugues, REZVANI, Katy, PALIOMPEIS, Christos, GOLDMAN, John M, MARIN, David, APPERLEY, Jane F, HOLYOAKE, Tessa L, SHEPHERD, Pat, DRUMMOND, Mark W, SZYDIO, Richard, BUA, Marco, FORONI, Letizia, REID, Alistair
Published in Haematologica (Roma) (01.02.2010)
Published in Haematologica (Roma) (01.02.2010)
Get full text
Journal Article
Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia
BARNES, David J, PALAIOLOGOU, Danai, PANOUSOPOULOU, Eleni, SCHULTHEIS, Beate, YONG, Agnes S. M, WONG, Alice, PATTACINI, Laura, GOLDMAN, John M, MELO, Junia V
Published in Cancer research (Chicago, Ill.) (01.10.2005)
Published in Cancer research (Chicago, Ill.) (01.10.2005)
Get full text
Journal Article
Posttransplantation imatinib as a strategy to postpone the requirement for immunotherapy in patients undergoing reduced-intensity allografts for chronic myeloid leukemia
Olavarria, Eduardo, Siddique, Shamyla, Griffiths, Michael J., Avery, Sharon, Byrne, Jenny L., Piper, Karen P., Lennard, Anne L., Pallan, Lalit, Arrazi, Julie M., Perz, Jolanta B., O'Shea, Derville, Goldman, John M., Apperley, Jane F., Craddock, Charles F.
Published in Blood (15.12.2007)
Published in Blood (15.12.2007)
Get full text
Journal Article
Optimizing patient selection for myeloablative allogeneic hematopoietic cell transplantation in chronic myeloid leukemia in chronic phase
Pavlů, Jiří, Kew, Andrea K., Taylor-Roberts, Beatrice, Auner, Holger W., Marin, David, Olavarria, Eduardo, Kanfer, Edward J., MacDonald, Donald H., Milojkovic, Dragana, Rahemtulla, Amin, Rezvani, Katayoun, Goldman, John M., Apperley, Jane F., Szydlo, Richard M.
Published in Blood (20.05.2010)
Published in Blood (20.05.2010)
Get full text
Journal Article
Cord blood stem cells for hematopoietic stem cell transplantation in the UK: how big should the bank be?
Querol, Sergio, Mufti, Ghulam J, Marsh, Steven G.E, Pagliuca, Antonio, Little, Ann-Margaret, Shaw, Bronwen E, Jeffery, Robert, Garcia, Joan, Goldman, John M, Madrigal, J. Alejandro
Published in Haematologica (Roma) (01.04.2009)
Published in Haematologica (Roma) (01.04.2009)
Get full text
Journal Article
What challenges remain in chronic myeloid leukemia research?
Carella, Angelo M, Branford, Susan, Deininger, Michael, Mahon, Francois X, Saglio, Giuseppe, Eiring, Anna, Khorashad, Jamshid, O'Hare, Thomas, Goldman, John M
Published in Haematologica (Roma) (01.08.2013)
Published in Haematologica (Roma) (01.08.2013)
Get full text
Journal Article
Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia
Dazzi, Francesco, Szydlo, Richard M., Cross, Nicholas C.P., Craddock, Charles, Kaeda, Jaspal, Kanfer, Ed, Cwynarski, Kate, Olavarria, Eduardo, Yong, Agnes, Apperley, Jane F., Goldman, John M.
Published in Blood (15.10.2000)
Published in Blood (15.10.2000)
Get full text
Journal Article